Metolazone Tablet
Product Images NDC 51079-024

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Metolazone (NDC 51079-024). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Metolazone 2.5 mg Tablets Unit Carton Label (Image 01)

Metolazone Tablets, USP IR, manufactured by Mylan, contain the active ingredient Metolazone and are used to treat high blood pressure and swelling caused by congestive heart failure or other kidney problems.*

FDA Label Image

Unit Carton (Image 02)

This text is a warning label found on a medication package. It indicates that the package is not child-resistant and is intended for institutional use only. The label emphasizes the importance of keeping the medication out of reach of children. The container is designed to protect its contents from light exposure. The package also provides information on identifying the lot number and expiration date. The manufacturer of the medication is Mylan® located in Rockford, IL, USA.*

FDA Label Image

Metolazone 5 mg Tablets Unit Carton Label (Image 03)

FDA Label Image

Unit Carton (Image 04)

FDA Label Image

Image 05

This unit dose package is not child-resistant and is for institutional use only. It's important to keep this and all drugs out of reach of children. The container provides light-resistance and the lot number and expiration date can be found on the window. The manufacturer is Mylan and the address is in Rockford, USA. No other information is available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.